Halma has bolstered its portfolio of technology companies by acquiring a Paris-based medical device company.
Halma has acquired French medical device manufacturer Lamidey Noury Medical for €50 million in cash. Lamidey Noury, which produces electrosurgical devices for minimally invasive surgery with distribution in over 60 countries, reported unaudited revenue of €13.6 million (£11.4 million) for the year to October 2024, with an EBIT margin exceeding 23%.
Lamidey Noury Medical has developed specialist tools for various surgical applications, including urology and gynaecology. The Paris-based company will operate as a standalone entity within Halma’s Healthcare Sector under its existing management team.
“Lamidey Noury is an exciting acquisition which will bring new minimally invasive surgical product capabilities to our Healthcare Sector,” said Marc Ronchetti, Group Chief Executive of Halma.
“Its advanced products improve patient outcomes and the efficiency of healthcare providers in treating the increasing incidence of urological and gynaecological disease. It is adjacent to our existing presence in diagnosis and biopsy devices for these diseases through Rovers Medical Devices and IZI Medical. We are delighted to welcome Lamidey Noury to Halma and look forward to supporting its development as it continues to scale its business globally.”